Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013

Eurosurveillance

Volumn 19, Issue 44, 2014, Pages

  Chatt, C ^a   Gajraj, R ^a   Hawker, J ^a   Neal, K ^a   Tahir, M ^a   Lawrence, M ^a   Gray, S J ^a   Lucidarme, J ^a   Carr, A D ^a   Clark, S A ^a   Fowler, T ^a,b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; PENICILLIN DERIVATIVE; RIFAMPICIN;

ARTICLE; CHEMOPROPHYLAXIS; CHILD; CLINICAL ARTICLE; FEVER; HUMAN; LETHARGY; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PORA SUBTYPING; MOLECULAR TYPING; NEISSERIA MENINGITIDIS; PHYLOGENY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PUBLIC HEALTH; QUESTIONNAIRE; RASH; SEROTYPE; TELEPHONE INTERVIEW; UNITED KINGDOM; VOMITING;

EID: 84922042285     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.44.20949     Document Type: Article

References (22)

1. de Assis Aquino Gondim F. Meningococcal meningitis. Background. New York: Medscape; December 2013. Available from: http: //emedicine.medscape.com/ article/1165557-overview#a0101
2. Public Health England (PHE). Meningococcal: the green book, chapter 22. London: PHE; March 2013. Available from: https: //www.gov.uk/government/publications/ meningococcal-the-green-book-chapter-22
3. Military Vaccine Agency-Vaccine Healthcare Centers Network. Questions and Answers. Meningococcal-the disease. Falls Church: Defense Health Headquarters. May 2014. Available from: https: //www.vaccines.mil/Questions_and_Answers/ Disease/Meningococcal/The_Disease
4. Centers for Disease Control and Prevention (CDC). Active bacterial core surveillance (ABCs) report emerging infections program network Neisseria meningitidis, 2012. Atlanta: CDC; December 2013. Available from: http: //www.cdc.gov/abcs/ reports-findings/survreports/mening12.pdf
5. European Centre for Disease Prevention and Control (ECDC). Surveillance of invasive bacterial diseases in Europe, 2011. Stockholm: ECDC; December 2013. Available from: http: // www.ecdc.europa.eu/en/publications/Publications/invasivebacterial-diseases-surveillance-2011.pdf
6. Public Health England (PHE). Health protection-collection. Meningococcal disease: guidance, data and analysis. London: PHE. [Accessed: January 29, 2014]. Available from: http: // www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ MeningococcalDisease/EpidemiologicalData/
7. European Centre for Disease Prevention and Control (ECDC). Public health management of sporadic cases of invasive meningococcal disease and their contacts. Stockholm: ECDC; October 2010. Available from: http: //www.ecdc.europa.eu/en/ publications/Publications/1010_GUI_Meningococcal_guidance. pdf
8. Hastings L, Stuart J, Andrews N, Begg N. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Commun Dis Rep CDR Rev. 1997; 7(13): R195-200. PMID: 9447784
9. Health Protection Agency. Guidance for public health management of meningococcal disease in the UK. London: HPA; March 2012. Available from: https: //www.gov.uk/ government/uploads/system/uploads/attachment_data/ file/322008/Guidance_for_management_of_meningococcal_ disease_pdf.pdf
10. Davison KL, Andrews N, White JM, Ramsay ME, Crowcroft NS, Rushdy AA, et al. Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk? Arch Dis Child. 2004; 89(3): 256-60. http: //dx.doi.org/10.1136/ adc.2003.031369 PMID: 14977705
11. Zangwill KM, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW, et al. School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. JAMA. 1997; 277(5): 389-95. http: //dx.doi.org/10.1001/ jama.1997.03540290041030 PMID: 9010171
12. Acheson P, Barron R, Borrow R, Gray S, Marodi C, Ramsay M, et al. A cluster of four cases of meningococcal disease in a single nuclear family. Arch Dis Child. 2012; 97(3): 248-9. http: //dx.doi. org/10.1136/archdischild-2011-301074 PMID: 22247241
13. Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Clin Infect Dis. 2013; 57(3): 344-8. http: //dx.doi. org/10.1093/cid/cit243 PMID: 23595832
14. Ashton P, Dallman T, Jenkins C, Perry N, Byrne L, Elson R, et al. The impact of whole-genome sequencing on the detection and investigation of outbreaks of Escherichia coli 0157: H7 in the UK. 23rd European Congress of Clinical Microbiology and Infectious Diseases (ESCMID),Berlin, 27-30 April 2013.
15. Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, Borrow R, et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol. 2006; 55(Pt 7): 887-96. http: //dx.doi.org/10.1099/jmm.0.46288-0 PMID: 16772416
16. Huson DH. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics. 1998; 14(1): 68-73. http: //dx.doi. org/10.1093/bioinformatics/14.1.68 PMID: 9520503
17. Clark SA, Lucidarme J, Newbold LS, Borrow R. Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens. PLoS ONE. 2014; 9(2): e89921. http: //dx.doi.org/10.1371/journal.pone.0089921 PMID: 24587125
18. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 1987; 99(3): 591-601. http: //dx.doi.org/10.1017/S0950268800066449 PMID: 3123263
19. Kaczmarski EB, Gray SJ, Carr AD, Mallard RH. Antimicrobial agent susceptibility of clinical Neisseria meningitidis isolates from England and Wales. Abstracts of the Thirtyninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 26-29 September 1999.
20. Buckee CO, Gupta S, Kriz P, Maiden MC, Jolley KA. Long-term evolution of antigen repertoires among carried meningococci. Proc Biol Sci. 2010; 277(1688): 1635-41. http: //dx.doi. org/10.1098/rspb.2009.2033 PMID: 20129981
21. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009; 27(Suppl 2): B51-63 http: //dx.doi.org/10.1016/j.vaccine.2009.04.063 PMID: 19477562
22. Ladhani S, Cordery R, Mandal S, Christensen H, Campbell H, Borrow R, et al. Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease: benefits of offering vaccination in addition to antibiotics chemoprophylaxis to close contacts of cases in the household, educational setting, clusters and wider community. London: Public Health England; April 2014. Available from: https: // www.gov.uk/government/uploads/system/uploads/ attachment_data/file/328835/Invasive_meningococcus_ secondary_case_prevention_April_2014.pdf